Aiforia Technologies Plc – Managers’ Transactions
Aiforia Technologies Plc
COMPANY RELEASE, MANAGERS’ TRANSACTIONS 10 May 5:00 p.m. EEST
___________________________________________________________
Person subject to the notification requirement
Name: Jukka Tapaninen
Position: Chief Executive Officer
Issuer: Aiforia Technologies Oyj
LEI: 743700TJRVBX7420Y723
Notification type: INITIAL NOTIFICATION
Reference number: 14530/5/5
___________________________________________________________
Transaction date: 2022-05-06
Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)
Instrument type: SHARE
ISIN: FI4000507934
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 255 Unit price: 4.3 EUR
(2): Volume: 647 Unit price: 4.499 EUR
(3): Volume: 146 Unit price: 4.2 EUR
(4): Volume: 99 Unit price: 4.1 EUR
(5): Volume: 100 Unit price: 4.7 EUR
(6): Volume: 506 Unit price: 4.49 EUR
(7): Volume: 160 Unit price: 4.4895 EUR
(8): Volume: 100 Unit price: 4.179 EUR
(9): Volume: 100 Unit price: 4.17 EUR
(10): Volume: 72 Unit price: 4.17 EUR
(11): Volume: 150 Unit price: 4.1 EUR
(12): Volume: 301 Unit price: 4.099 EUR
(13): Volume: 142 Unit price: 4.0495 EUR
(14): Volume: 30 Unit price: 4 EUR
(15): Volume: 520 Unit price: 3.9915 EUR
(16): Volume: 178 Unit price: 3.991 EUR
(17): Volume: 500 Unit price: 3.991 EUR
(18): Volume: 25 Unit price: 3.991 EUR
(19): Volume: 38 Unit price: 3.95 EUR
(20): Volume: 238 Unit price: 4.049 EUR
(21): Volume: 11 Unit price: 3.9 EUR
Aggregated transactions
(21): Volume: 4318 Volume weighted average price: 4.21575 EUR
Further enquiries
Veli-Matti Parkkonen, CFO, Aiforia Technologies Plc, tel. +358405009878
https://investors.aiforia.com/
Certified Adviser
UB Securities Ltd, tel. +358 9 25 380 225
About Aiforia
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities, across a variety of fields from oncology to neuroscience and more. Find out more: www.aiforia.com